Healthcare M&A and Valuation
News and Insights

On March 11, 2025, Better Choice Company, Inc. (NYSE American: BTTR) signed a binding Letter of Intent to acquire  100 % of Choice Specialty Pharmacy Group, a fully licensed U.S. provider of specialty pharmacy and infusion clinic services with an integrated sterile compounding facility, under an option purchase agreement. The transaction, which is expected to close later in 2025 following exercise of the option, strengthens Better Choice’s footprint in healthcare services alo

On March 6, 2025, Walgreens Boots Alliance, Inc. (Nasdaq: WBA)  entered into a definitive agreement to be acquired by New York‑based private equity firm Sycamore Partners in a take‑private transaction valued at up to $23.7 billion in total consideration. Under the terms of the deal, WBA shareholders received $11.45 per share in cash at closing plus a non‑transferable right to receive up to an additional $3.00 per share from the future monetization of Walgreens’ interests in